BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

703 related articles for article (PubMed ID: 33645548)

  • 1. Immune checkpoint inhibitor-associated myocarditis: manifestations and mechanisms.
    Moslehi J; Lichtman AH; Sharpe AH; Galluzzi L; Kitsis RN
    J Clin Invest; 2021 Mar; 131(5):. PubMed ID: 33645548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiotoxicity of Immune Checkpoint Inhibitors.
    Patel RP; Parikh R; Gunturu KS; Tariq RZ; Dani SS; Ganatra S; Nohria A
    Curr Oncol Rep; 2021 May; 23(7):79. PubMed ID: 33937956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Research Progress of Immune Checkpoint Inhibitor-associated Myocarditis].
    Liu Y; Chen Y; Zeng Z; Liu A
    Zhongguo Fei Ai Za Zhi; 2021 Sep; 24(9):668-672. PubMed ID: 34521189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Strategy for the Diagnosis and Treatment of Immune Checkpoint Inhibitor-Associated Myocarditis: A Narrative Review.
    Lehmann LH; Cautela J; Palaskas N; Baik AH; Meijers WC; Allenbach Y; Alexandre J; Rassaf T; Müller OJ; Aras M; Asnani AH; Deswal A; Laufer-Perl M; Thuny F; Kerneis M; Hayek SS; Ederhy S; Salem JE; Moslehi JJ
    JAMA Cardiol; 2021 Nov; 6(11):1329-1337. PubMed ID: 34232253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-cell RNA sequencing reveals the altered innate immunity in immune checkpoint inhibitor-related myocarditis.
    Lou B; Guo M; Zheng T; Liu J; Wang C; Chen T; Chen F; Fan X; Gao S; Liang X; Qiang H; Li L; Zhou B; Yuan Z; She J
    Immunology; 2024 Jun; 172(2):235-251. PubMed ID: 38425094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular Toxicity Associated With Immune Checkpoint Inhibitor Therapy: A Comprehensive Review.
    Chitsazan M; Amin A; Ladel L; Baig A; Chitsazan M
    Crit Pathw Cardiol; 2023 Sep; 22(3):69-82. PubMed ID: 37363862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electrocardiographic Features of Immune Checkpoint Inhibitor-Associated Myocarditis.
    Song W; Zheng Y; Dong M; Zhong L; Bazoukis G; Perone F; Li G; Ng CF; Baranchuk A; Tse G; Liu T
    Curr Probl Cardiol; 2023 Feb; 48(2):101478. PubMed ID: 36336121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective screening for myocarditis in cancer patients treated with immune checkpoint inhibitors.
    Furukawa A; Tamura Y; Taniguchi H; Kawamura A; Nagase S; Hayashi A; Tada Y; Sase K; Hatake K
    J Cardiol; 2023 Jan; 81(1):63-67. PubMed ID: 35953399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heart-Specific Immune Responses in an Animal Model of Autoimmune-Related Myocarditis Mitigated by an Immunoproteasome Inhibitor and Genetic Ablation.
    Bockstahler M; Fischer A; Goetzke CC; Neumaier HL; Sauter M; Kespohl M; Müller AM; Meckes C; Salbach C; Schenk M; Heuser A; Landmesser U; Weiner J; Meder B; Lehmann L; Kratzer A; Klingel K; Katus HA; Kaya Z; Beling A
    Circulation; 2020 Jun; 141(23):1885-1902. PubMed ID: 32160764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune checkpoint inhibitor cardiotoxicity: Breaking barriers in the cardiovascular immune landscape.
    Zhu H; Ivanovic M; Nguyen A; Nguyen PK; Wu SM
    J Mol Cell Cardiol; 2021 Nov; 160():121-127. PubMed ID: 34303670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of Biomarkers in the Management of Immune-Checkpoint Inhibitor-Related Myocarditis.
    Vasbinder A; Ismail A; Salem JE; Hayek SS
    Curr Cardiol Rep; 2023 Sep; 25(9):959-967. PubMed ID: 37436648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New Insights into Mechanisms of Immune Checkpoint Inhibitor-Induced Cardiovascular Toxicity.
    Khunger A; Battel L; Wadhawan A; More A; Kapoor A; Agrawal N
    Curr Oncol Rep; 2020 Jun; 22(7):65. PubMed ID: 32514647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune Checkpoint Inhibitor Myocarditis With Normal Cardiac Magnetic Resonance Imaging: Importance of Cardiac Biopsy and Early Diagnosis.
    Ederhy S; Fenioux C; Cholet C; Rouvier P; Redheuil A; Cohen A; Salem JE
    Can J Cardiol; 2021 Oct; 37(10):1654-1656. PubMed ID: 33373722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Re-introducing immunotherapy in patients surviving immune checkpoint inhibitors-mediated myocarditis.
    Peleg Hasson S; Salwen B; Sivan A; Shamai S; Geva R; Merimsky O; Raphael A; Shmilovich H; Moshkovits Y; Kapusta L; Rozenbaum Z; Wolf I; Laufer-Perl M
    Clin Res Cardiol; 2021 Jan; 110(1):50-60. PubMed ID: 32296970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recurrent Myocarditis Induced by Immune-Checkpoint Inhibitor Treatment Is Accompanied by Persistent Inflammatory Markers Despite Immunosuppressive Treatment.
    Aghel N; Gustafson D; Di Meo A; Music M; Prassas I; Seidman MA; Hansen AR; Thavendiranathan P; Diamandis EP; Delgado D; Fish JE
    JCO Precis Oncol; 2021 Mar; 5():. PubMed ID: 34337287
    [No Abstract]   [Full Text] [Related]  

  • 16. A retrospective study of immune checkpoint inhibitor-associated myocarditis in a single center in China.
    Wang F; Sun X; Qin S; Hua H; Liu X; Yang L; Yang M
    Chin Clin Oncol; 2020 Apr; 9(2):16. PubMed ID: 32279526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical characteristics, time course, treatment and outcomes of patients with immune checkpoint inhibitor-associated myocarditis.
    Puzanov I; Subramanian P; Yatsynovich YV; Jacobs DM; Chilbert MR; Sharma UC; Ito F; Feuerstein SG; Stefanovic F; Switzer B; Hicar MD; Curtis AB; Spangenthal EJ; Dy GK; Ernstoff MS; Vachhani P; Page BJ; Agrawal N; Khunger A; Kapoor A; Hattoum A; Schentag JJ
    J Immunother Cancer; 2021 Jun; 9(6):. PubMed ID: 34162715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac myosin-specific autoimmune T cells contribute to immune-checkpoint-inhibitor-associated myocarditis.
    Won T; Kalinoski HM; Wood MK; Hughes DM; Jaime CM; Delgado P; Talor MV; Lasrado N; Reddy J; Čiháková D
    Cell Rep; 2022 Nov; 41(6):111611. PubMed ID: 36351411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Genetic Mouse Model Recapitulates Immune Checkpoint Inhibitor-Associated Myocarditis and Supports a Mechanism-Based Therapeutic Intervention.
    Wei SC; Meijers WC; Axelrod ML; Anang NAS; Screever EM; Wescott EC; Johnson DB; Whitley E; Lehmann L; Courand PY; Mancuso JJ; Himmel LE; Lebrun-Vignes B; Wleklinski MJ; Knollmann BC; Srinivasan J; Li Y; Atolagbe OT; Rao X; Zhao Y; Wang J; Ehrlich LIR; Sharma P; Salem JE; Balko JM; Moslehi JJ; Allison JP
    Cancer Discov; 2021 Mar; 11(3):614-625. PubMed ID: 33257470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune checkpoint inhibitor-associated myocarditis: a systematic analysis of case reports.
    Wang C; Zhao G; Zhang Z; Yang L; Liu S; Li G; Wang H; Huang J; Wang S; Li N
    Front Immunol; 2023; 14():1275254. PubMed ID: 37876928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.